High-Risk HPV DNA PCR Testing & Genotyping in Bangalore
Advanced molecular screening for Human Papillomavirus. Identifying oncogenic high-risk genotypes 16 and 18 for cervical cancer prevention and wart management.
Evidence-Based Understanding & Diagnostic Protocol
Human Papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Over 100 strains exist, broadly categorized into High-Risk (oncogenic) and Low-Risk (non-oncogenic) types.
High-risk HPV types (predominantly 16 and 18, along with 31, 33, 45, 52, 58) are the primary cause of cervical cancer, anal cancer, and oropharyngeal cancers. These high-risk strains do NOT cause visible genital warts; they cause silent cellular dysplasia.
Conversely, low-risk HPV types 6 and 11 cause benign genital warts (condylomata acuminata) and do not lead to cancer. High-Risk HPV DNA PCR detects oncogenic strains years before cellular abnormalities appear on a Pap smear.
Key Clinical Takeaways
- High-risk HPV causes silent cellular changes; low-risk HPV causes visible benign genital warts.
- HPV DNA PCR is more sensitive and reliable than a traditional Pap smear alone.
- Most healthy immune systems naturally clear HPV infections within 12 to 24 months.
- Co-testing (HPV DNA + Liquid-Based Cytology) is the gold standard cervical screening protocol.
Available Laboratory Assays & Pricing
NABL-accredited diagnostic investigations performed under strict ISO 15189:2022 standards.
| Investigation / Assay | Specimen Type | Window / Timing | Turnaround Time | Price (₹) |
|---|---|---|---|---|
High-Risk HPV DNA PCR (14/16 Genotypes) Specifically identifies HPV 16 and 18, with pooled high-risk group detection. | Cervical Swab / Vaginal Swab / Anatomical Swab | Routine / Annual Screening | 48–72 Hours | ₹2,800 |
Liquid-Based Cytology (Pap Smear) + HPV Co-Test Evaluates cellular morphology alongside oncogenic HPV viral DNA. | Cervical Sample in ThinPrep/SurePath | Routine Screening | 3–5 Days | ₹3,400 |
Physical Central Facilities in Bengaluru
Samples are processed directly at our NABL-accredited reference laboratory facilities in Kengeri and Yelahanka, operating under ISO 15189:2022 standards (Certificate No. MC-6849). No third-party outsourcing.
100% Discrete Patient Privacy Guarantee
- Numeric Barcoding: Laboratory samples are processed via alphanumeric barcodes without patient names on testing tubes.
- Encrypted Digital PDF: Password-protected lab reports delivered exclusively to your private WhatsApp or email.
- Discreet Phlebotomy: Trained phlebotomy specialists available in plain clothes with temperature-controlled cold chain.
Direct Questions & Clinical Answers
Clear, transparent answers designed for patient clarity and AI-assisted search retrieval.
